Stable gene silencing of cyclin B1 in tumor cells increases susceptibility to taxol and leads to growth arrest in vivo

Oncogene

Volumn 25, Issue 12, 2006, Pages 1753-1762

  Yuan, J ^a   Kramer A ^a   Matthess, Y ^a   Yan, R ^b   Spankuch B ^a   Gatje R ^a   Knecht, R ^a   Kaufmann, M ^a   Strebhardt, K ^a  

^a GOETHE UNIVERSITY   (Germany)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cyclin B1; Inhibition in vivo; RNA interference; Taxol

Indexed keywords

ANTIINFECTIVE AGENT; CYCLIN B1; PACLITAXEL; POLO LIKE KINASE 1; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE G2 PHASE; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME CONDENSATION; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; GENE SILENCING; GENETIC SUSCEPTIBILITY; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MITOSIS; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PLASMID; PRIORITY JOURNAL; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; CYCLIN B; DOWN-REGULATION; GENE SILENCING; HELA CELLS; HUMANS; MICE; MICE, NUDE; PACLITAXEL; TRANSFECTION;

MUS MUSCULUS;

EID: 33645033152     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209202     Document Type: Article

References (45)

1. Brandeis M, Rosewell I, Carrington M, Crompton T, Jacobs MA, Kirk J et al. (1998). Proc Natl Acad Sci USA 95: 4344-4349.
2. Carnero A. (2002). Br J Cancer 87: 129-133.
3. Chang TH, Schlegel R. (1996). J Cell Biochem 60: 161-172.
4. Eckerdt F, Yuan J, Strebhardt K. (2005). Oncogene 24: 267-276.
5. Garrett MD, Fattaey A. (1999). Curr Opin Genet Dev 9: 104-111.
6. Glotzer M, Murray AW, Kirschner MW. (1991). Nature 349: 132-138.
7. Hagting A, Karlsson C, Clute P, Jackman M, Pines J. (1998). EMBO J 17: 4127-4138.
8. Hassan KA, Ang KK, El-Naggar AK, Story MD, Lee JI, Liu D et al. (2002). Cancer Res 62: 6414-6417.
9. Hassan KA, El-Naggar AK, Soria JC, Liu D, Hong WK, Mao L. (2001). Clin Cancer Res 7: 2458-2462.
10. Hunter T, Pines J. (1994). Cell 79: 573-582.
11. Jackman M, Lindon C, Nigg EA, Pines J. (2003). Nat Cell Biol 5: 143-148.
12. Jin P, Hardy S, Morgan DO. (1998). J Cell Biol 141: 875-885.
13. Jordan MA, Wilson L. (2004). Nat Rev Cancer 4: 253-265.
14. Kao GD, McKenna WG, Maity A, Blank K, Muschel RJ. (1997). Cancer Res 57: 753-758.
15. Kaufmann WK, Schwartz JL, Hurt JC, Byrd LL, Galloway DA, Levedakou E et al. (1997). Cell Growth Differ 8: 1105-1114.
16. Korenaga D, Takesue F, Yasuda M, Honda M, Nozoe T, Inutsuka S. (2002). Surgery 131(1 Suppl): 114-120.
17. Lehner CF, O'Farrell PH. (1990). Cell 61: 535-547.
18. Li J, Meyer AN, Donoghue DJ. (1997). Proc Natl Acad Sci USA 94: 502-507.
19. Liu X, Erikson RL. (2002). Proc Natl Acad Sci USA 99: 8672-8676.
20. Matthess Y, Kappel S, Spankuch B, Zimmer B, Kaufmann M, Strebhardt K. (2005). Oncogene 24: 2973-2980.
21. Norbury C, Nurse P. (1992). Annu Rev Biochem 61: 441-470.
22. Park M, Chae HD, Yun J, Jung M, Kim YS, Kim SH et al. (2000). Cancer Res 60: 542-545.
23. Pines J, Hunter T. (1989). Cell 58: 833-846.
24. Sarafan-Vasseur N, Lamy A, Bourguignon J, Pessot FL, Hieter P, Sesboue R et al. (2002). Oncogene 21: 2051-2057.
25. Senderowicz AM. (2003). Oncogene 22: 6609-6620.
26. Shen M, Feng Y, Gao C, Tao D, Hu J, Reed E et al. (2004). Cancer Res 64: 1607-1610.
27. Sherr CJ, Roberts JM. (2004). Genes Dev 18: 2699-2711.
28. Solomon MJ, Glotzer M, Lee TH, Philippe M, Kirschner MW. (1990). Cell 63: 1013-1024.
29. Soria JC, Jang SJ, Khuri FR, Hassan KA, Liu D, Hong WK et al. (2000). Cancer Res 60: 4000-4004.
30. Spankuch B, Matthess Y, Knecht R, Zimmer B, Kaufmann M, Strebhardt K. (2004). J Natl Cancer Inst 96: 862-871.
31. Spankuch-Schmitt B, Bereiter-Hahn J, Kaufmann M, Strebhardt K. (2002). J Natl Cancer Inst 94: 1863-1877.
32. Takeno S, Noguchi T, Kikuchi R, Uchida Y, Yokoyama S, Muller W. (2002). Cancer 94: 2874-2881.
33. Taylor WR, DePrimo SE, Agarwal A, Agarwal ML, Schonthal AH, Katula KS et al. (1999). Mol Biol Cell 10: 3607-3622.
34. Toyoshima F, Moriguchi T, Wada A, Fukuda M, Nishida E. (1998). EMBO J 17: 2728-2735.
35. Viallard JF, Lacombe F, Dupouy M, Ferry H, Belloc F, Reiffers J. (1999). Exp Cell Res 247: 208-219.
36. Walsh S, Margolis SS, Kornbluth S. (2003). Mol Cancer Res 1: 280-289.
37. Yang J, Bardes ES, Moore JD, Brennan J, Powers MA, Kornbluth S. (1998). Genes Dev 12: 2131-2143.
38. Yang J, Song H, Walsh S, Bardes ES, Kornbluth S. (2001). J Biol Chem 276: 3604-3609.
39. Yasuda M, Takesue F, Inutsuka S, Honda M, Nozoe T, Korenaga D. (2002). J Cancer Res Clin Oncol 128: 412-416.
40. Yin XY, Grove L, Datta NS, Katula K, Long MW, Prochownik EV. (2001). Cancer Res 61: 6487-6493.
41. Yoshida T, Tanaka S, Mogi A, Shitara Y, Kuwano H. (2004). Ann Oncol 15: 252-256.
42. Yuan J, Eckerdt F, Bereiter-Hahn J, Kurunci-Csacsko E, Kaufmann M, Strebhardt K. (2002a). Oncogene 21: 8282-8292.
43. Yuan J, Kramer A, Eckerdt F, Kaufmann M, Strebhardt K. (2002b). Cancer Res 62: 4186-4190.
44. Yuan J, Strebhardt K. (2005). Lett Drug Design Disc 2: 274-281.
45. Yuan J, Yan R, Kramer A, Eckerdt F, Roller M, Kaufmann M et al. (2004). Oncogene 23: 5843-5852.